Listed

Sunshine Biopharma Inc.

SBFMNasdaqCIK 1402328HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$9.3m, Q2 FY2026
Operating income−$1.6m, Q2 FY2026
Net income−$1.6m, Q2 FY2026
Sunshine Biopharma Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k5,958Revenue, Q3 FY2023, three months to 2023-09-30$6.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure7,680Revenue, Q4 FY2023, three months to 2023-12-31$7.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure7,541Revenue, Q1 FY2024, three months to 2024-03-31$7.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure9,303Revenue, Q2 FY2024, three months to 2024-06-30$9.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure8,435Revenue, Q3 FY2024, three months to 2024-09-30$8.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure9,595Revenue, Q4 FY2024, three months to 2024-12-31$9.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure8,901Revenue, Q1 FY2025, three months to 2025-03-31$8.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure9,410Revenue, Q2 FY2025, three months to 2025-06-30$9.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure9,417Revenue, Q3 FY2025, three months to 2025-09-30$9.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure8,577Revenue, Q4 FY2025, three months to 2025-12-31$8.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure8,089Revenue, Q1 FY2026, three months to 2026-03-31$8.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure9,264Revenue, Q2 FY2026, three months to 2026-06-30$9.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Cost of revenue$k3,967Cost of revenue, Q3 FY2023, three months to 2023-09-30$4.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure5,112Cost of revenue, Q4 FY2023, three months to 2023-12-31$5.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure5,187Cost of revenue, Q1 FY2024, three months to 2024-03-31$5.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure6,947Cost of revenue, Q2 FY2024, three months to 2024-06-30$6.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure5,569Cost of revenue, Q3 FY2024, three months to 2024-09-30$5.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure6,502Cost of revenue, Q4 FY2024, three months to 2024-12-31$6.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure6,171Cost of revenue, Q1 FY2025, three months to 2025-03-31$6.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure5,987Cost of revenue, Q2 FY2025, three months to 2025-06-30$6.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure6,344Cost of revenue, Q3 FY2025, three months to 2025-09-30$6.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure5,548Cost of revenue, Q4 FY2025, three months to 2025-12-31$5.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure5,908Cost of revenue, Q1 FY2026, three months to 2026-03-31$5.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure6,837Cost of revenue, Q2 FY2026, three months to 2026-06-30$6.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Gross profit$k1,990Gross profit, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure2,568Gross profit, Q4 FY2023, three months to 2023-12-31$2.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure2,354Gross profit, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure2,356Gross profit, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure2,866Gross profit, Q3 FY2024, three months to 2024-09-30$2.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure3,093Gross profit, Q4 FY2024, three months to 2024-12-31$3.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure2,730Gross profit, Q1 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure3,423Gross profit, Q2 FY2025, three months to 2025-06-30$3.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure3,074Gross profit, Q3 FY2025, three months to 2025-09-30$3.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure3,029Gross profit, Q4 FY2025, three months to 2025-12-31$3.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure2,181Gross profit, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure2,427Gross profit, Q2 FY2026, three months to 2026-06-30$2.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Research and development$k238Research and development, Q3 FY2023, three months to 2023-09-30$238.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure816Research and development, Q4 FY2023, three months to 2023-12-31$816.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure222Research and development, Q1 FY2024, three months to 2024-03-31$222.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure436Research and development, Q2 FY2024, three months to 2024-06-30$436.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure126Research and development, Q3 FY2024, three months to 2024-09-30$126.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure149Research and development, Q4 FY2024, three months to 2024-12-31$149.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure215Research and development, Q1 FY2025, three months to 2025-03-31$215.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure196Research and development, Q2 FY2025, three months to 2025-06-30$196.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure119Research and development, Q3 FY2025, three months to 2025-09-30$119.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure73.5Research and development, Q4 FY2025, three months to 2025-12-31$73.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure31.7Research and development, Q1 FY2026, three months to 2026-03-31$31.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure13.2Research and development, Q2 FY2026, three months to 2026-06-30$13.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Operating income$k(779)Operating income, Q3 FY2023, three months to 2023-09-30−$779.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure(1,187)Operating income, Q4 FY2023, three months to 2023-12-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure(1,351)Operating income, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure(1,268)Operating income, Q2 FY2024, three months to 2024-06-30−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure(1,106)Operating income, Q3 FY2024, three months to 2024-09-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure(2,038)Operating income, Q4 FY2024, three months to 2024-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure(1,296)Operating income, Q1 FY2025, three months to 2025-03-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(2,055)Operating income, Q2 FY2025, three months to 2025-06-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure(1,087)Operating income, Q3 FY2025, three months to 2025-09-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure(1,790)Operating income, Q4 FY2025, three months to 2025-12-31−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure(1,396)Operating income, Q1 FY2026, three months to 2026-03-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(1,613)Operating income, Q2 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Interest expense$k38.5Interest expense, Q3 FY2023, three months to 2023-09-30$38.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001683168-23-007911.Report this figure30.1Interest expense, Q4 FY2023, three months to 2023-12-31$30.1k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-28, accession 0001683168-24-001818. Derived: 12-month figure less the 9-month figure.Report this figure49.2Interest expense, Q1 FY2024, three months to 2024-03-31$49.2k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-20, accession 0001683168-24-003688.Report this figure0.2Interest expense, Q2 FY2024, three months to 2024-06-30$245. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure8.5Interest expense, Q4 FY2024, three months to 2024-12-31$8.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$k41.0Income tax, Q3 FY2023, three months to 2023-09-30$41.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure220Income tax, Q4 FY2023, three months to 2023-12-31$220.3k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure22.4Income tax, Q1 FY2024, three months to 2024-03-31$22.4k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure(344)Income tax, Q2 FY2024, three months to 2024-06-30−$343.7k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure215Income tax, Q3 FY2024, three months to 2024-09-30$215.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure(129)Income tax, Q4 FY2024, three months to 2024-12-31−$128.7k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure(40.2)Income tax, Q1 FY2025, three months to 2025-03-31−$40.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(209)Income tax, Q2 FY2025, three months to 2025-06-30−$209.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure(137)Income tax, Q3 FY2025, three months to 2025-09-30−$137.4k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure408Income tax, Q4 FY2025, three months to 2025-12-31$408.4k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Net income$k(651)Net income, Q3 FY2023, three months to 2023-09-30−$651.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure(1,250)Net income, Q4 FY2023, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure(1,284)Net income, Q1 FY2024, three months to 2024-03-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure(494)Net income, Q2 FY2024, three months to 2024-06-30−$494.3k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure(1,198)Net income, Q3 FY2024, three months to 2024-09-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure(2,158)Net income, Q4 FY2024, three months to 2024-12-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure(1,180)Net income, Q1 FY2025, three months to 2025-03-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(1,771)Net income, Q2 FY2025, three months to 2025-06-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure(884)Net income, Q3 FY2025, three months to 2025-09-30−$883.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure(2,141)Net income, Q4 FY2025, three months to 2025-12-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure(1,244)Net income, Q1 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(1,564)Net income, Q2 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Diluted EPS$ per sharenot reportednot reported(2.00)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$2.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure(43.48)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$43.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figurenot reportednot reported(0.44)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure(0.82)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figurenot reportednot reportednot reportednot reported
Basic EPS$ per share(50.72)Basic EPS, Q3 FY2023, three months to 2023-09-30−$50.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figurenot reported(2.00)Basic EPS, Q1 FY2024, three months to 2024-03-31−$2.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure(9.94)Basic EPS, Q2 FY2024, three months to 2024-06-30−$9.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure(0.94)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figurenot reported(0.44)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(3.94)Basic EPS, Q2 FY2025, three months to 2025-06-30−$3.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure(0.19)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figurenot reported(0.25)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(1.15)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure

Balance sheet

Shareholders' equity$27.5m, Q2 FY2026
Sunshine Biopharma Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current assets$m25.4Current assets, Q3 FY2023, at 2023-09-30$25.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001683168-23-007911.Report this figure24.9Current assets, FY2023, at 2023-12-31$24.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-04-01, accession 0001683168-25-002184.Report this figure28.8Current assets, Q1 FY2024, at 2024-03-31$28.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-20, accession 0001683168-24-003688.Report this figure25.7Current assets, Q2 FY2024, at 2024-06-30$25.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-08-20, accession 0001683168-24-005931.Report this figure26.0Current assets, Q3 FY2024, at 2024-09-30$26.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure26.0Current assets, FY2024, at 2024-12-31$26.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-04-03, accession 0001683168-26-002644.Report this figure24.5Current assets, Q1 FY2025, at 2025-03-31$24.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure27.9Current assets, Q2 FY2025, at 2025-06-30$27.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure28.0Current assets, Q3 FY2025, at 2025-09-30$28.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure26.9Current assets, FY2025, at 2025-12-31$26.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure24.8Current assets, Q1 FY2026, at 2026-03-31$24.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure30.7Current assets, Q2 FY2026, at 2026-06-30$30.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Total assets$m27.7Total assets, Q3 FY2023, at 2023-09-30$27.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001683168-23-007911.Report this figure27.3Total assets, FY2023, at 2023-12-31$27.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-04-01, accession 0001683168-25-002184.Report this figure31.9Total assets, Q1 FY2024, at 2024-03-31$31.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-20, accession 0001683168-24-003688.Report this figure29.3Total assets, Q2 FY2024, at 2024-06-30$29.3m. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-08-20, accession 0001683168-24-005931.Report this figure30.1Total assets, Q3 FY2024, at 2024-09-30$30.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure30.6Total assets, FY2024, at 2024-12-31$30.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-04-03, accession 0001683168-26-002644.Report this figure29.2Total assets, Q1 FY2025, at 2025-03-31$29.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure32.0Total assets, Q2 FY2025, at 2025-06-30$32.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure31.5Total assets, Q3 FY2025, at 2025-09-30$31.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure30.1Total assets, FY2025, at 2025-12-31$30.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure27.9Total assets, Q1 FY2026, at 2026-03-31$27.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure33.6Total assets, Q2 FY2026, at 2026-06-30$33.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Current liabilities$m5.1Current liabilities, Q3 FY2023, at 2023-09-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001683168-23-007911.Report this figure5.6Current liabilities, FY2023, at 2023-12-31$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-04-01, accession 0001683168-25-002184.Report this figure6.5Current liabilities, Q1 FY2024, at 2024-03-31$6.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-20, accession 0001683168-24-003688.Report this figure5.3Current liabilities, Q2 FY2024, at 2024-06-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-08-20, accession 0001683168-24-005931.Report this figure4.5Current liabilities, Q3 FY2024, at 2024-09-30$4.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure6.3Current liabilities, FY2024, at 2024-12-31$6.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-04-03, accession 0001683168-26-002644.Report this figure5.8Current liabilities, Q1 FY2025, at 2025-03-31$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure5.6Current liabilities, Q2 FY2025, at 2025-06-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure6.7Current liabilities, Q3 FY2025, at 2025-09-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure6.4Current liabilities, FY2025, at 2025-12-31$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure5.9Current liabilities, Q1 FY2026, at 2026-03-31$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure5.6Current liabilities, Q2 FY2026, at 2026-06-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Total liabilities$m5.7Total liabilities, Q3 FY2023, at 2023-09-30$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001683168-23-007911.Report this figure6.1Total liabilities, FY2023, at 2023-12-31$6.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-04-01, accession 0001683168-25-002184.Report this figure7.1Total liabilities, Q1 FY2024, at 2024-03-31$7.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-20, accession 0001683168-24-003688.Report this figure5.8Total liabilities, Q2 FY2024, at 2024-06-30$5.8m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-08-20, accession 0001683168-24-005931.Report this figure5.0Total liabilities, Q3 FY2024, at 2024-09-30$5.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure7.1Total liabilities, FY2024, at 2024-12-31$7.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-04-03, accession 0001683168-26-002644.Report this figure6.5Total liabilities, Q1 FY2025, at 2025-03-31$6.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure6.3Total liabilities, Q2 FY2025, at 2025-06-30$6.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure7.3Total liabilities, Q3 FY2025, at 2025-09-30$7.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure7.0Total liabilities, FY2025, at 2025-12-31$7.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure6.4Total liabilities, Q1 FY2026, at 2026-03-31$6.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure6.1Total liabilities, Q2 FY2026, at 2026-06-30$6.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m22.0Shareholders' equity, Q3 FY2023, at 2023-09-30$22.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure21.2Shareholders' equity, FY2023, at 2023-12-31$21.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-04-03, accession 0001683168-26-002644.Report this figure24.8Shareholders' equity, Q1 FY2024, at 2024-03-31$24.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure23.5Shareholders' equity, Q2 FY2024, at 2024-06-30$23.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure25.0Shareholders' equity, Q3 FY2024, at 2024-09-30$25.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure23.5Shareholders' equity, FY2024, at 2024-12-31$23.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure22.7Shareholders' equity, Q1 FY2025, at 2025-03-31$22.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure25.7Shareholders' equity, Q2 FY2025, at 2025-06-30$25.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure24.2Shareholders' equity, Q3 FY2025, at 2025-09-30$24.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001683168-25-008328.Report this figure23.0Shareholders' equity, FY2025, at 2025-12-31$23.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure21.5Shareholders' equity, Q1 FY2026, at 2026-03-31$21.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure27.5Shareholders' equity, Q2 FY2026, at 2026-06-30$27.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure

Cash flow

Operating cash flow−$918.0k, Q2 FY2026
Capital expenditure$7.0k, Q2 FY2026
Share repurchases$0, Q4 FY2025
Sunshine Biopharma Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(457)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$457.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0001683168-24-007622. Derived: 9-month figure less the 6-month figure.Report this figure(2,690)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure(3,185)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure(4,578)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001683168-25-005981. Derived: 6-month figure less the 3-month figure.Report this figure(1,357)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001683168-25-008328. Derived: 9-month figure less the 6-month figure.Report this figure(3,405)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure(1,695)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(1,273)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001683168-26-006340. Derived: 6-month figure less the 3-month figure.Report this figure(747)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$746.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001683168-25-008328. Derived: 9-month figure less the 6-month figure.Report this figure(1,616)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure(2,072)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure(918)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$918.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001683168-26-006340. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k9.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$9.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0001683168-24-007622. Derived: 9-month figure less the 6-month figure.Report this figure(382)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$382.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure62.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$62.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure975Capital expenditure, Q2 FY2024, three months to 2024-06-30$974.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001683168-25-005981. Derived: 6-month figure less the 3-month figure.Report this figure517Capital expenditure, Q3 FY2024, three months to 2024-09-30$517.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001683168-25-008328. Derived: 9-month figure less the 6-month figure.Report this figure103Capital expenditure, Q4 FY2024, three months to 2024-12-31$102.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure7.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$7.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure160Capital expenditure, Q2 FY2025, three months to 2025-06-30$160.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001683168-26-006340. Derived: 6-month figure less the 3-month figure.Report this figure8.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001683168-25-008328. Derived: 9-month figure less the 6-month figure.Report this figure(1.0)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure5.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001683168-26-003819.Report this figure7.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001683168-26-006340. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$knot reported0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-04-01, accession 0001683168-25-002184. Derived: 12-month figure less the 9-month figure.Report this figure3,140Share repurchases, Q1 FY2024, three months to 2024-03-31$3.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-12, accession 0001683168-25-005981. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-13, accession 0001683168-25-008328. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-12, accession 0001683168-25-005981. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-13, accession 0001683168-25-008328. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-04-03, accession 0001683168-26-002644. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)3.60m, Q2 FY2025
Sunshine Biopharma Inc., shares, quarterly
Line itemUnitQ1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30
Diluted shares (weighted)m shares5.3Diluted shares (weighted), Q1 FY2022, three months to 2022-03-315,272,856 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-10, accession 0001683168-23-003121.Report this figure15.8Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3015,849,518 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-10, accession 0001683168-23-005518.Report this figure18.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3018,885,632 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001683168-23-007911.Report this figure0.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31220,363 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-20, accession 0001683168-24-003688.Report this figure0.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3012,675 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-08-20, accession 0001683168-24-005931.Report this figure0.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3012,845 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure0.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31641,310 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure0.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3040,896 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure1.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,267,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001683168-24-007622.Report this figure2.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-312,703,293 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001683168-25-003701.Report this figure3.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-303,604,653 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001683168-25-005981.Report this figure

Shares outstanding: 3.88mShares outstanding, period not labelled, at 2026-08-133,877,337 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001683168-26-006340.Report this figure at Aug 13, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.